BridgeMD
Compares treatment options for Postoperative Analgesia
Official title PENG vs Deep Iliacus Plane Block in Intertrochanteric Femur Fractures
ClinicalTrials.gov ID: NCT07513740
What this study is testing
What is Intravenous Analgesia?
Intravenous Analgesia is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for postoperative analgesia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Intertrochanteric femur fractures are common in elderly patients and are associated with significant pain. Providing effective analgesia is clinically important both during positioning for spinal anesthesia and in the postoperative period in this patient population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patients scheduled for elective surgery for intertrochanteric femur fractures
- Patients with ASA physical status I, II, or III
- Patients aged between 30 and 85 years
You likely can't join if
- Patients with ASA physical status IV or higher
- Patients undergoing emergency surgery
- Patients who refuse to participate or withdraw consent during the study
- Patients with cognitive dysfunction such as Alzheimer's disease, dementia, or delirium
- Patients with a history of local anesthetic toxicity
- Patients with infection at the planned block site
See the full eligibility criteria
- Patients scheduled for elective surgery for intertrochanteric femur fractures
- Patients with ASA physical status I, II, or III
- Patients aged between 30 and 85 years
- Patients with ASA physical status IV or higher
- Patients undergoing emergency surgery
- Patients who refuse to participate or withdraw consent during the study
- Patients with cognitive dysfunction such as Alzheimer's disease, dementia, or delirium
- Patients with a history of local anesthetic toxicity
- Patients with infection at the planned block site
- Patients with bleeding diathesis
- Patients undergoing additional surgical procedures or additional anesthesia (e.g., general anesthesia)
- Patients with a history of chronic opioid use or receiving treatment for neuropathic pain
The study team makes the final eligibility decision.
Where it's taking place
- Erzincan, Merkez/Türkiye, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erzincan, Merkez/Türkiye, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.